You Can Get More Cord Blood Stem Cells With Americord
At Americord one of the ways we measure how well we are doing for our clients is by measuring how many cord blood stem cells we collect and preserve. An in-depth analysis just completed on our collections through March 31, 2014 revealed that Americord collects 60% more CD34+ stem cells, 54% higher volume, and 34% higher total nucleated cells (TNCs) than the industry median for other cord blood banks. (You can read more about what CD34+ stem cells are and why they are important here).
How does Americord achieve those amazing stem cell collection numbers? We use the highest quality collection bags, we always use an expedited medical courier service, and processing of the stem cells is done in our CLIA Certified, AABB accredited laboratory.
Soon, with the launch of CordAdvantage, a proprietary product we are in the final stages of developing, Americord will be able to help our clients collect up to twice the number of stem cells from umbilical cord blood by harvesting cells from both the umbilical cord blood and placenta.
Collecting and preserving as many stem cells as possible is the most important thing we can do because one of the current limitations of stem cell therapy is that the volume of stem cells in a typical cord blood collection is insufficient to effectively treat an adult patient (or anyone over approximately 65 pounds on average).
Bottom line: more stem cells means greater opportunities for stem cell therapy in the future should your baby or family ever need it. Check out our recent press release online here.